Zipnosis, maker of white-labeled telemedicine products for providers, launched a new platform called ZipPlus, which helps providers using the company's telemedicine services carve out an integrated “roadmap.”
“We continue to hear from our health system customers that virtual care deployment is narrow and integration is a challenge, and in many cases prohibiting widespread adoption,” Jon Pearce, CEO of Zipnosis, said in a statement. “ZipPlus breaks down these barriers in two ways. The first barrier is technology. Within the ZipPlus program, we can fully integrate the patient and provider experience via FHIR or APIs into Epic, Cerner and Athena.
"The second barrier is an aligned strategy for virtualizing care. With ZipPlus, Zipnosis and our partners sit down to create a multi-year roadmap for clinical business lines, such as behavioral health, post-surgical follow-up, travel medicine, hypertension — or any service using our powerful virtual care technology platform as the foundation. These unique roadmap partnerships are truly a first for the industry and position us well as the undisputed standard in virtual care.”
…
This morning Medidata, a New York City-based company that provides cloud storage and data analytics services for clinical trials, announced the launch of its latest product Acorn AI. The new technology is geared to help the R&D space by employing artificial intelligence to give “actionable insights" and assist companies as they commercialize their products.
"Life science firms are looking at data-centric and AI-based business models to revamp functions such as drug discovery, R&D, clinical trial and commercial operations; to cater to an evolving patient profile, a converging ecosystem, and emerging therapy areas," Nitish Mittal, practice director at Everest Group, said in a statement. "They are looking for strategic partners that can deliver AI-as-a-Service, underwriting their risk of innovation. Medidata's new venture, Acorn AI, builds on a combination of deep life science pedigree, proprietary data sets and AI methodologies to help life science customers reimagine their operating model."
…
Remote patient monitoring company LindaCare has recently launched a new platform designed to help monitor implantable devices. The new technology, named ProPulse, will be able to give patients and providers a way to see what is happening with a patient's cardiac device.
LindaCare employs certified device technicians to make sure that the patient's devices are consistently transmitting. The team is able to review the patient data and alert clinicians if there is an issue.
“We are excited to debut the new ProPulse Remote Monitoring service at the American College of Cardiology Scientific Sessions," Dr. Robert Lerman, LindaCare’s chief medical officer, said in a statement. "Remote monitored patients have a higher survival than those followed only in device clinics. Remote monitoring promotes rapid detection of clinical events and changes in device function, leading to faster intervention than routine in-office follow-up. While commercializing our OnePulse software platform in the US, we saw an immediate need for a more service-oriented solution: ProPulse.”
….
Today senior-focused VR company MyndVR announced that it has teamed up with HTC Vive’s VR accelerator, VIVE X, to launch the second version of the former’s signature VR product. Called MyndVR 2.0, the updated software is a VR experience for senior care communities.
The tool will offer residents of those communities different experiences aimed at tackling engagement and boosting cognitive health. The tool is able to work on the Vive Focus headset along with a table.
“At Vive we believe in VR’s potential to reshape humanity for the better using emerging technology and we’re excited to work with MyndVR to bring virtual reality content to improve the lives of senior populations,” Cher Wang, chairwoman and CEO of HTC, said in a statement. “Through these positive and life-like experiences, with the help of Vive Focus, virtual reality is improving the quality of life for these individuals and we’re proud to be a part of this life-changing initiative.”
